1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]piperazine, 95.0%, 25g

1-Boc-4-Formyl-4-methylpiperidine, 95.0%, 10g

1-Butyl-1-methylpyrrolidin-1-ium trifluoromethanesulfonate, 98.0%, 100g

2-Chloro-3-((trimethylsilyl)ethynyl)pyridin-4-amine, 97%, 1g

2-((2-Methylquinolin-6-yl)oxy)acetic acid, 97%, 250mg

2-Ethyl-5-methylfuran, 95+%, 1g

Zernike phase contrast set PLPHi 10/20/40/100 IOS bright field and dark field position

4-Hydroxyphenylacetone>97.0%(GC)(T)5g

1-(4-decylphenyl)ethan-1-one, 5g

Sodium 2,2,3,3,3-pentafluoropropanoate, 98%, 100g

BENZYL ALLYL(2,2-DIMETHOXYETHYL)CARBAMATE, 95.0%, 1g

1-((2-(Dimethylamino)ethyl)amino)-7-hydroxy-4-(hydroxymethyl)-9H-xanthen-9-one, 95.0%, 1g

(5-Cyano-1H-indol-2-yl)boronic acid, 95.0%, 500mg